BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8585199)

  • 1. Critical review of protease-treated red cell tests for the detection of irregular blood group antibodies during pregnancy.
    Jemmolo G; Malferrari F; Tazzari PL; Conte R
    Vox Sang; 1995; 69(2):144. PubMed ID: 8585199
    [No Abstract]   [Full Text] [Related]  

  • 2. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 4. Consequences for fetus and neonate of maternal red cell allo-immunisation.
    Howard H; Martlew V; McFadyen I; Clarke C; Duguid J; Bromilow I; Eggington J
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F62-6. PubMed ID: 9536844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early 'enzyme' Rh antibodies and second pregnancies.
    Murray S
    Vox Sang; 1971 Sep; 21(3):217-21. PubMed ID: 5000853
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of anti-G.
    Lenkiewicz B; Zupańska B
    Transfus Med; 2002 Jun; 12(3):221. PubMed ID: 12071879
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of enzyme-treated red blood cell surface and haemagglutination using a theory of soft-particle electrophoresis.
    Hyono A; Mazda T; Okazaki H; Tadokoro K; Ohshima H
    Vox Sang; 2008 Aug; 95(2):131-6. PubMed ID: 18510578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of haemolytic disease of the newborn due to anti-D.
    Tovey G; Wagstaff W
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575
    [No Abstract]   [Full Text] [Related]  

  • 9. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of red cell fragility in anti-D hemolytic disease of the newborn.
    GREENWALT TJ; TRIANTAPHYLLOPOULOS DC
    J Lab Clin Med; 1955 Jan; 45(1):135-40. PubMed ID: 13233638
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of anti-Rh O antibody as part of the programme in the prevention of Rh isoimmunization in Rh-negative mothers in Australia.
    Simmons RT
    Haematologia (Budap); 1972; 6(1):165-71. PubMed ID: 4112704
    [No Abstract]   [Full Text] [Related]  

  • 13. An example of anti-Coa found in pregnancy.
    Smith DS; Stratton F; Howell P; Riches R
    Vox Sang; 1970 Jan; 18(1):62-6. PubMed ID: 4984719
    [No Abstract]   [Full Text] [Related]  

  • 14. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
    Tovey LA; Taverner JM
    Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody dependent cell mediated cytotoxicity against anti-D sensitized human erythrocytes. Influence of various effector cells and enzyme treatment of the target cells.
    Samdal HH; Michaelsen TE; Heier HE; Nordhagen R
    APMIS; 1988 Mar; 96(3):250-6. PubMed ID: 3126786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-anti-D antibodies in red-cell alloimmunization.
    Lobo GA; Nardozza LM; Camano L
    Int J Gynaecol Obstet; 2006 Aug; 94(2):139-40. PubMed ID: 16828096
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
    Dajak S; Stefanović V; Capkun V
    Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.